# FDA Inspection 910018 - Rochester General Hospital - December 23, 2014

Source: https://www.keypedia.com/records/fda_inspections/rochester-general-hospital/975dd4c8-c9e8-4f19-830b-8aa7e06e279d
Source feed: FDA_Inspections

> FDA Inspection 910018 for Rochester General Hospital on December 23, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 910018
- Company Name: Rochester General Hospital
- Inspection Date: 2014-12-23
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1243917 - 2024-07-11](https://www.keypedia.com/records/fda_inspections/rochester-general-hospital/eb42732f-c39c-4020-a5e7-3bdde102e075)
- [FDA Inspection 1172733 - 2022-06-17](https://www.keypedia.com/records/fda_inspections/rochester-general-hospital/a968b8b8-25f4-4d2a-8c4e-6299f1f11c6e)
- [FDA Inspection 1172733 - 2022-06-17](https://www.keypedia.com/records/fda_inspections/rochester-general-hospital/2a26219b-ce27-492a-a198-729c46bbb418)
- [FDA Inspection 1032322 - 2017-11-14](https://www.keypedia.com/records/fda_inspections/rochester-general-hospital/38fd75d3-1541-49ae-92e8-d5114c5cbc83)
- [FDA Inspection 952986 - 2015-12-09](https://www.keypedia.com/records/fda_inspections/rochester-general-hospital/87ac194b-641a-41f9-9224-b2feb747ccf7)

Company: https://www.keypedia.com/companies/rochester-general-hospital/a42617ee-9a6e-456b-8988-1ed39dd501cb

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d